Novel directions for the management of dual antiplatelet therapy in patients with coronary artery disease

Dual antiplatelet therapy has been extensively studied in the last two decades, giving opportunities for thorough evidence-based recommendations. The ESC/EACTS guidelines on DAPT in CAD provide guidance for DAPT type and duration, maintaining a patient-centred focus. Patient-specific and dynamic evaluation of the ischaemic and bleeding risks is key for optimal treatment decisions.

Gender differences in cardiac interventions

Differences in pathophysiology, clinical presentation, and outcomes of cardiovascular disease in men and women have been known for decades, but are not fully understood; women are underrepresented in most cardiovascular trials. Furthermore, women remain a minority in interventional cardiology and clinical cardiac electrophysiology.

Women in cardiology: past, present and future

In 2018, the Swiss Society of Cardiology celebrated its 70th year. Is this also a celebration for the achievement of women in cardiology? Yes and no. 

Diagnostic accuracy of transthoracic three-dimensional left ventricular function analysis compared with cardiac magnetic resonance imaging: a bivariate meta-analysis

Minimal use of contrast media in patients with severe chronic kidney disease undergoing transcatheter aortic valve implantation

Gadolinium-free MR can be used for pre-procedural annular and iliofemoral assessment, and thus selection of prosthesis size.

The effect of lithoplasty on the coronary arteries

The authors present the case of a 79-year-old gentleman presenting with non-ST-elevation myocardial infarction and a heavily calcified bifurcation stenosis of the left anterior descending and the diagonal branch. Intravascular lithoplasty was used to prepare the extremely calcified lesion. 

Pascal Meier ‒ new head of cardiology at the Kantonsspital Graubünden

Förderungspreis USGG / Prix d’encouragement USSMV

Schweizer Preis für Angiologie 2019 / Prix Suisse d’angiologie 2019

24th Scientific Meeting of the International Society of Cardiovascular Pharmacotherapy (ISCP)